NAT Diagnostics, Inc. — Form D/A
NAT Diagnostics, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2015-09-11. The offering totals $2.9M, of which $2.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-09-11
- Form: D/A
- Accession: 0001640306-15-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.9M
- Amount sold: $2.9M
- Minimum investment: $5K
- Investors: 18
- Date of first sale: 2015-04-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-238489
Issuer
- Name: NAT Diagnostics, Inc.
- CIK: 0001640306
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 11585 Sorrento Valley Rd., Ste. 107, SAN DIEGO, CA, 92121
- Phone: (858) 531-3129
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Thomas J Wu | Director | San Diego, CA |
| David J Galas | Director | San Diego, CA |
| Allan J Fan | Director | San Diego, CA |
| Andrew P Miller | Director | San Diego, CA |
| Andrew P Miller | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More